Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong
· Delayed Price · Currency is HKD 69.10
+3.15 (4.78%)
Mar 10, 2026, 1:55 PM HKT
Shanghai Henlius Biotech Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Market Capitalization | 35,843 | 12,881 | 7,555 | 6,957 | 11,984 | 25,517 | Upgrade
|
| Market Cap Growth | 213.30% | 70.50% | 8.59% | -41.95% | -53.03% | 15.21% | Upgrade
|
| Enterprise Value | 38,799 | 16,522 | 11,112 | 10,233 | 13,635 | 25,011 | Upgrade
|
| Last Close Price | 65.95 | 23.70 | 13.90 | 12.80 | 22.05 | 46.95 | Upgrade
|
| PE Ratio | 39.68 | 14.75 | 12.56 | - | - | - | Upgrade
|
| Forward PE | 38.32 | 15.91 | 12.55 | - | - | - | Upgrade
|
| PS Ratio | 5.64 | 2.11 | 1.27 | 1.91 | 5.80 | 36.57 | Upgrade
|
| PB Ratio | 9.60 | 4.02 | 3.13 | 3.76 | 4.25 | 6.72 | Upgrade
|
| P/TBV Ratio | - | - | - | - | 25.87 | 12.46 | Upgrade
|
| P/FCF Ratio | 21.41 | 11.23 | 11.94 | 15.51 | - | - | Upgrade
|
| P/OCF Ratio | 18.57 | 9.75 | 6.54 | 6.27 | 108.01 | - | Upgrade
|
| EV/Sales Ratio | 6.11 | 2.71 | 1.87 | 2.82 | 6.60 | 35.84 | Upgrade
|
| EV/EBITDA Ratio | 27.85 | 13.36 | 10.82 | - | - | - | Upgrade
|
| EV/EBIT Ratio | 41.37 | 17.92 | 15.45 | - | - | - | Upgrade
|
| EV/FCF Ratio | 23.17 | 14.40 | 17.57 | 22.82 | - | - | Upgrade
|
| Debt / Equity Ratio | 1.08 | 1.21 | 1.87 | 2.25 | 1.14 | 0.57 | Upgrade
|
| Debt / EBITDA Ratio | 2.89 | 2.96 | 4.07 | - | - | - | Upgrade
|
| Debt / FCF Ratio | 2.40 | 3.39 | 7.13 | 9.27 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.79 | 0.94 | 1.41 | 1.81 | 0.82 | 0.22 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.25 | 2.44 | 3.31 | -7.06 | -3.63 | -0.84 | Upgrade
|
| Net Debt / FCF Ratio | 1.77 | 2.63 | 5.37 | 7.48 | -5.08 | -0.60 | Upgrade
|
| Asset Turnover | 0.54 | 0.56 | 0.57 | 0.40 | 0.25 | 0.10 | Upgrade
|
| Inventory Turnover | 1.73 | 2.07 | 1.95 | 1.44 | 1.44 | 0.84 | Upgrade
|
| Quick Ratio | 0.46 | 0.34 | 0.34 | 0.27 | 0.35 | 0.67 | Upgrade
|
| Current Ratio | 0.68 | 0.50 | 0.53 | 0.44 | 0.56 | 0.97 | Upgrade
|
| Return on Equity (ROE) | 27.54% | 31.52% | 28.52% | -35.35% | -35.81% | -27.60% | Upgrade
|
| Return on Assets (ROA) | 4.97% | 5.28% | 4.33% | -4.88% | -6.11% | -9.37% | Upgrade
|
| Return on Invested Capital (ROIC) | 13.69% | 15.11% | 12.67% | -14.32% | -16.48% | -29.95% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.50% | 15.60% | 13.50% | -16.00% | -15.80% | -20.70% | Upgrade
|
| Earnings Yield | 2.52% | 6.78% | 7.96% | -11.30% | -10.08% | -4.62% | Upgrade
|
| FCF Yield | 4.67% | 8.91% | 8.37% | 6.45% | -3.79% | -5.43% | Upgrade
|
| Buyback Yield / Dilution | 0.00% | -0.02% | -0.25% | -0.59% | -1.75% | -6.52% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.